Abstract Details

Title Immunogenicity with Repeated Dosing of Ocrelizumab in Patients with Multiple Sclerosis

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 087

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
Robert Hendricks	No disclosure on file
	No disclosure on file
Qing Wang	Qing Wang has nothing to disclose.
Peter S. Chin, MD (Denali)	No disclosure on file
Hideki Garren, MD, PhD	Dr. Garren has received personal compensation for serving as an employee of Prothena. Dr. Garren has received personal compensation for serving as an employee of Genentech. Dr. Garren has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Coya.

��ɫ����